CINECA IRIS Institutional Research Information System

ALLEGRA, Sarah
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.444
EU - Europa 2.008
AS - Asia 784
AF - Africa 22
SA - Sud America 21
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.417
IT - Italia 569
CN - Cina 363
IE - Irlanda 275
SE - Svezia 270
DK - Danimarca 235
SG - Singapore 178
DE - Germania 129
FR - Francia 119
AT - Austria 72
FI - Finlandia 72
UA - Ucraina 68
VN - Vietnam 65
GB - Regno Unito 62
IN - India 56
KR - Corea 28
BE - Belgio 27
HK - Hong Kong 21
PL - Polonia 21
CA - Canada 20
JP - Giappone 19
NL - Olanda 19
ES - Italia 18
CZ - Repubblica Ceca 13
AU - Australia 10
GR - Grecia 10
BR - Brasile 9
TR - Turchia 9
RO - Romania 8
TW - Taiwan 8
MX - Messico 6
EG - Egitto 5
IR - Iran 5
PK - Pakistan 5
SI - Slovenia 5
UZ - Uzbekistan 5
CH - Svizzera 4
ID - Indonesia 4
IQ - Iraq 4
NG - Nigeria 4
TH - Thailandia 4
ZA - Sudafrica 4
A1 - Anonimo 3
EC - Ecuador 3
EU - Europa 3
PE - Perù 3
RU - Federazione Russa 3
SN - Senegal 3
AR - Argentina 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
KE - Kenya 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 6.295
Salva come PNG Salva come JPEG
Città #
Ann Arbor 616
Chandler 571
Dublin 274
Beijing 208
Torino 158
Fairfield 154
Singapore 144
Nyköping 138
Houston 128
Turin 112
Woodbridge 96
Wilmington 93
Ashburn 92
Villeurbanne 88
Dearborn 87
Medford 78
Vienna 71
Princeton 59
Jacksonville 53
Cambridge 52
Seattle 45
Redwood City 40
Fremont 38
Dong Ket 34
Milan 32
Boardman 27
Guangzhou 22
New York 22
Brussels 21
Pisa 21
Warsaw 19
Nanjing 18
Munich 15
Santa Clara 15
Los Angeles 14
Rome 14
Brno 13
Boston 12
Toronto 12
San Diego 11
Shanghai 11
Falls Church 10
Hefei 10
Hebei 9
Hong Kong 9
Catania 8
Hangzhou 8
Chicago 7
Jinan 7
Nanchang 7
Pune 7
Taipei 7
Washington 7
Mumbai 6
Norwalk 6
Nürnberg 6
Shenzhen 6
West Jordan 6
Esslingen am Neckar 5
Florence 5
Helsinki 5
Lappeenranta 5
Philadelphia 5
Seoul 5
Verona 5
Zgornje Gorje 5
Abuja 4
Albano Laziale 4
Assago 4
Bari 4
Copenhagen 4
Delhi 4
Hyderabad 4
Kunming 4
London 4
Madrid 4
Mountain View 4
Nuremberg 4
San Mateo 4
Silver Spring 4
Stockholm 4
The Bronx 4
Tianjin 4
Upper Marlboro 4
Aberdeen 3
Athens 3
Baghdad 3
Barolo 3
Boulder 3
Bucharest 3
Busto Arsizio 3
Chandigarh 3
Chengdu 3
Dallas 3
Guiyang 3
Islamabad 3
Kumar 3
Lanzhou 3
Lebanon 3
Leiden 3
Totale 4.014
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 387
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. 303
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. 232
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B 187
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 184
VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. 169
Role of pharmacogenetics on deferasirox AUC and efficacy 163
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 160
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. 159
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir 153
UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells 144
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 133
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics 132
Pharmacogenetics of ribavirin-induced anemia in HCV patients 130
"Procedimento per determinare glifosato e acido aminometilfosfonico in un campione" 129
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 117
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. 115
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study 110
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy 101
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 98
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 97
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 96
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 93
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 90
Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon 89
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients 88
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 88
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples 86
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness. 85
Deferasirox AUC efficacy cutoff and role of pharmacogenetics 85
Efavirenz pharmacogenetics in a cohort of Italian patients 81
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics 78
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness 76
NURR1 deficiency is associated to ADHD-like phenotypes in mice 75
Clinical relevance of deferasirox trough levels in β-thalassemia patients 74
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations 74
Pharmacogenomic influence on sepsis outcome in critically ill patients 74
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 72
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 67
The influence of sex, gender and age on COVID-19 data in the Piedmont region: the virus prefers men 67
A Common mdr1 Gene Polymorphism is Associated with Changes in Linezolid Clearance 65
Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients 64
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring 63
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 63
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 62
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 61
DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR OROTIC ACID AND OROTIDINE 5’-MONOPHOSPHATE DETECTION IN HUMAN PLASMA AND URINE 59
EFFECT OF SEASONS ON FOUR ANTI-EPILEPTIC DRUGS PLASMA LEVELS 58
GENDER ANALYSIS ON COVID-19 DATA IN PIEMONTE: THE VIRUS PREFERS MEN 57
Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics 56
Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir. 54
Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration 53
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 53
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 53
Precision medicine for HIV: where are we? 52
Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration-Time Curve of Linezolid for Different ABCB1 Genotypes 49
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment 48
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients 47
Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma 43
NURR1-deficient mice have age- and sex-specific behavioral phenotypes 38
Procedimento per determinare glifosato e acido aminometilfosfonico in un campione 36
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 35
La fluidità dei confini: il diritto alla salute ha un genere? 33
GENDER-SPECIFIC SIDE EFFECTS OF CHEMOTHERAPY IN PANCREATIC CANCER PATIENTS 33
Determinazione del glifosato su matrici organiche e inorganiche: valutazione degli effetti tossici 29
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 27
The Influence of sex, gender, and age on COVID-19 data in the Piedmont Region (Northwest Italy): the virus prefers men 27
Mass Spectrometry approach to quantifying orotic acid and its metabolites in urine 26
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 25
A convenient method for extraction and analysis with high-pressure liquid chromatography of cathecholamine neurotransmitters in plasma and brain samples of mice 24
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study 21
Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities? 21
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma 20
Cancer Genetics and Clinical Research 19
Development and validation of an HPLC method for orotic acid and orotidine 5’-monophosphate detection in human plasma and urine 18
Influence of seasonal variation and gender on anti-epileptic drugs pharmacokinetics 17
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 17
Gender analysis on COVID-19 data in piemonte: the virus prefers men 17
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 16
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 16
A convenient method for extraction and analysis with High-Pressure Liquid Chromatography of catecholamine neurotransmitters in plasma and brain samples of mice 15
“New standardised procedure to extract glyphosate and aminomethylphosphonic acid (ampa) from organic and inorganic matrices: toward a practical kit for hplc-uv detection” 15
Effect of seasons on four anti-epileptic drugs plasma levels 14
The Strange Case of Orotic Acid: the different expression of pyrimidines biosynthesis in heathy males and females 14
Age and Sex-Related Differences in Teicoplanine Isoform Concentrations in SARS-CoV-2 Patients 12
Phytotherapy and Drugs: Can Their Interactions Increase Side Effects in Cancer Patients?” 11
COVID-19 Prevention and Treatment 10
Gender differences in five different drug pharmacokinetics 9
Posaconazole plasma concentrations in children and adolescent 8
Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Comparison of Deferasirox Formulations for Treatment Tailoring 7
Evaluation of sex differences in preclinical pharmacology re-search: how far still to go? 7
Pharmacokinetics of four tyrosine kinase inhibitors in adult and paediatric chronic myeloid leukaemia patients 7
Gender Medicine and Pharmacology 4
PHARMACOKINETICS AND PHARMACOGENETICS OF DEFERASIROX FOR IRON OVERLOAD TREATMENT IN BETA-THALASSAEMIA PATIENTS 2
Totale 6.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.785
article - articoli 0
book - libri 0
conference - conferenze 3.687
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020822 0 0 30 61 77 176 81 52 78 89 82 96
2020/2021711 59 49 32 42 57 49 30 16 76 29 132 140
2021/20221.239 69 78 105 103 85 125 88 72 54 62 227 171
2022/20231.648 125 142 52 143 177 408 101 123 180 41 113 43
2023/2024744 101 127 68 48 63 42 21 32 18 43 60 121
2024/2025193 39 128 26 0 0 0 0 0 0 0 0 0
Totale 6.651